Andre finansieringskilder (eng)

New grants from The European and Developing Countries Clinical Trials Partnership (EDCTP)

EDCTP announced the opening of the Strategic Primer Grants, which are funds supporting clinical research studies to develop and test clinical interventions against HIV/AIDS, tuberculosis or malaria.

The EDTCP has made available a maximum of EUR 5,500,000 to fund awards of between EUR 300,000 and EUR 800,000 for clinical research studies of up to two years duration that address high priority research issues and barriers to progress. The purpose of these grants is to pump-prime research into novel and innovative ways that may lead to the development and testing of new or improved clinical interventions against HIV/AIDS, malaria or tuberculosis.

Applications must involve researchers from publicly funded institutions in two or more EDCTP-EEIG Member States, and one or more publicly funded institutions in sub-Saharan Africa. Applications to support research projects undertaken in collaboration with private or public partnerships are encouraged.

The Strategic Primer grants will provide funding for research groups that will:

Generate results to inform future clinical trials;
Sustain and strengthen the capacity built up under EDCTP I; and
Increase networking of African and European Member States’ research programmes.

The deadline for submission of Letters of Intent (LoI) is 14 February 2012. Decisions on the LoI will be available by 20 March 2012. The deadline for full applications is 31 May 2012. Decisions on the full applications will be available by 31 July 2012 and successful applicants should sign the EDCTP grant contract by 30 September 2012. All projects must be completed by 30 September 2014.

All necessary information can be found on EDCTP's website.

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Innovative Medicine Initiative (IMI) calls for 2012

IMI has released two indicative topics for the 2012 call that are still under consideration by the IMI Governing Board.

The Innovative Medicines Initiative (IMI) is Europe's largest public-private partnership aiming to improve the drug development process by supporting a more efficient discovery and development of better and safer medicines for patients. With a €2 billion euro budget, IMI supports collaborative research projects and builds networks of industrial and academic experts in Europe that will boost innovation in healthcare. The overall objective of IMI is to remove bottlenecks hampering the efficiency of the development of new medicines and thus provide faster access to better medicines for European citizens, as well as enable the European bio-pharmaceutical industry to become world leaders.

The IMI Governing Board is currently considering the following topics for the 2012 call:

European lead factory: building a joint European compound library and screening centre; and
Antibiotics research to tackle resistant bacteria.

All necessary information - including the Scientific Research Agenda, Calls for Proposals and Key Research Priorities - can be found on IMI's website.

Excellence Project for Young Researchers within Endocrinology

The Novo Nordisk Foundation Excellence Project 2012 consists of up to four five-year grants of 5 million Danish kroner each (one million Danish kroner annually). It is possible to apply for projects within the fields of basic, translational and/or clinical endocrinology research. Deadline for letter of intent: 23 January 2012.

Prerequisites

The projects must be carried out in a Nordic country (Denmark, Finland, Iceland, Norway or Sweden). The project must be of high international standard. Applicants must have completed their PhD within the past seven years. Applicants may be clinicians or experimental researchers.

Project grants

Each project is granted one million Danish kroner annually for five years. The grant covers project costs, such as own payroll and operational expenses.

Process

The Foundation’s application system is to be used for the entire application process. The process begins with the submission of a letter of intent with deadline 23 January 2012. By 8 February 2012, the Foundation will inform if the applicant can expect to proceed. The applicant is then asked to prepare a project application with a deadline of 5 March 2012. The final decision will be made on 19 March at which date the applicant should be prepared to participate in an interview with the committee in Copenhagen.

All letters of intent and project descriptions will be assessed by the Foundation’s Nordic Research Committee.

Official celebration

Please note that the grants will be awarded on 29 March 2012 in the afternoon at an official celebration in the Foundation’s premises at Tuborg Havnevej. Once we know the names of the grantees, program and invitation will be sent out.

Internet-based application system

The application form with detailed guidelines is available on the Novo Nordisk Foundation’s website, from 20 December 2011. The letter of intent is to be completed using the Internet-based application system and submitted electronically to the Foundation no later than 4 p.m. on 23 January 2012.

Applications must be completed in English, whether or not the applicants have Danish, Norwegian or Swedish as their native language.

Support for events - clinical research

The Norwegian Research Council's programme KLINISKFORSKNING seeks to enhance the knowledge base for preventive measures, diagnostic methods, and treatment and rehabilitation measures through clinical trials. The programme supports events, giving priority to national and interdisciplinary competence-building and network-building activities. The call is open-ended.

Clinical trials

The KLINISKFORSKNING programme gives greatest priority to projects involving multiregional, national and international clinical trials. Within the dental health services, general practice and the primary health care services at large, priority will also be given to smaller-scale studies. These do not have to be multiregional, national or international in character.

No thematic limitations

No thematic limitations have been stipulated in the field of clinical research under the programme. All clinical research projects involving controlled trials on patients of preventive measures, diagnostic methods, and treatment and rehabilitation measures are of relevance, although emphasis will be placed on studies of diseases and disorders that pose considerable challenges to society in human or economic terms.

Multidisciplinary cooperation

The programme seeks to promote multidisciplinary cooperation across health regions and municipalities and will give priority to national and interdisciplinary competence-building and network-building activities to achieve this. Projects rooted in international cooperation will be seen in a positive light.

For more information, see the Norwegian Research Council's website

Funding for research on sudden infant death syndrome and sudden fetal death

Landsforeningen for uventet barnedød (LUB) announces financial support to research on sudden death during pregnancy, babyhood and early childhood. Application deadline: 15 January 2012.

Projects related to research on sudden infant death syndrome and fetal death will be prioritized. LUB also encourages research on grief and grief process.

For more information, see LUB's website (Norwegian only)

ERC Advanced Investigator Grants

ERC Advanced Grants allow exceptional established research leaders of any nationality, any age and from any scientific field to pursue ground-breaking, high-risk projects that open new directions in their respective research fields or other domains.

The deadline for Life Sciences Domain is 14 March 2012.

Who can apply?
The ERC Advanced Grant scheme targets researchers who have an exceptional scientific leadership profile and who have a track record of significant achievements appropriate to their field(s) of research in the last ten years. The applicants should be exceptional leaders in terms of originality and significance of their own research contributions and pursue ground-breaking, highrisk research that opens new directions in their respective research fields or other domains.

What kind of projects are financed?
The proposed projects should tackle pioneering and far-reaching challenges at the frontiers of the field(s) addressed, and involve new, ground-breaking or unconventional methodologies, whose risky outlook is justified by the possibility of a major breakthrough with an impact beyond a specific research domain/discipline. The main evaluation criterion is scientific excellence.

Funding and duration
Normally, one can apply for up to € 2.5 million (in some circumstances up to € 3.5 million) for a period of up to 5 years.

All important documents like Call Fiche, Guide for the Applicant and Work Programme can be downloaded from the EU Research Participant Portal.

The Nansen fund and related funds

Application deadline for "Nansenfondet og de dermed forbundne fond" is 15 January 2012, and grants will be awarded the same year. The maximum amount for each applicant is normally 50 000 NOK per year.

The application process is administrated by UNIFOR and it is possible to apply from 1 December 2011.

See Guide for applicants (Norwegian only)

See the funds' statutes (Norwegian only)

European Research Council - Synergy Grants

The European Research Council (ERC) has launched its first ever Synergy Grant Call for Proposals with deadline 25th January 2012.

Aim
Synergy Grants will enable small groups of two to four Principal Investigators (PIs) and their teams to bring together complementary skills, knowledge, and resources, in order to jointly address research problems at the frontier of knowledge.

The peer review evaluation will therefore look for proposals that demonstrate synergies, complementarities and added value that could lead to breakthroughs that would not be possible by the individual PIs working alone.

Who can be financed?
ERC Synergy Grants will fund projects for groups of between two and four PIs who are excellent researchers, to undertake frontier research of their choice. As for existing ERC schemes, the PIs can also apply for funding for team members. The PIs can be from different disciplines or can be working in the same/similar fields, and they can be based either at the same or different institutions.

Budget
Each Synergy Grant can be up to a maximum of EUR 15 million for a period of up to six years. The budget for this pilot call is EUR 150 million, meaning that about ten proposals are likely to be funded.

All important documents connected to this call are to be found on the Participant Portal.